We have all the drug pricing news that’s fit to summarize. Welcome to the Week in Review in prescription drug pricing!
1. Almost Isn’t Good Enough
- In an effort to reduce the public scrutiny around exorbitant insulin prices, Eli Lilly has began sales of its “half-priced” generic version of Humalog. It’s still not enough. — (CBS News)
2. Too. Much.
- Novartis is charging more than $2 million for a gene therapy it can’t take full credit for. — (CNN)
3. Taken Hostage
- Hackers aren’t the only hostage-takers in Baltimore. The self-insured city had filed an antitrust suit against a Johnson&Johnson subsidiary, accusing the drug maker of thwarting generic competition for an expensive cancer drug. — (The Baltimore Sun)
4. First in the Nation
- Spunky Maryland’s new drug pricing affordability board will be enacted July 1. We expect more reforms to come from states this year. — (AP)
5. It’s Personal
- P4AD founder David Mitchell spoke with Houston Public Media about the importance of addressing the rising costs of prescription drugs. — (Houston Public Media)